DIASTOLIC DYSFUNCTION AND HEART FAILURE PHYSIOLOGY, HISTORICAL FEATURES AND CLINICAL PERSPECTIVE Medicine Resident Rounds September 28, 2007 Jacobi Hospital.

Slides:



Advertisements
Similar presentations
Cardiac Risk In ESRD Patient
Advertisements

RET 1024 Introduction to Respiratory Therapy
The Third & Fourth (S3 &S4) Chapter 9
A Look Into Congestive Heart Failure By Tim Gault.
Congestive Heart Failure
Heart Failure. Objectives Describe congestive heart failure Explain the pathophysiology of congestive heart failure Describe nursing interventions in.
 Heart failure is a complex clinical syndrome Can result from:  structural or functional cardiac disorder  impairs the ability of the ventricle to.
Diastolic Heart Failure, HFpEF, HFnEF: What are we treating anyway? Charles M. Rasmussen, MD FACC.
Congestive heart failure
Cardiovascular System
Mitral Stenosis. Etiology Most cases of mitral stenosis are due to rheumatic fever The rheumatic process causes immobility and thickening of the mitral.
Coronary Artery Disease Megan McClintock. Coronary Artery Disease Definition Etiology/Pathophysiology Risk Factors –Unmodifiable –Modifiable Signs & symptoms.
1 Cardiac Pathophysiology Part B. 2 Heart Failure The heart as a pump is insufficient to meet the metabolic requirements of tissues. Can be due to: –
Bio-Med 350 Normal Heart Function and Congestive Heart Failure.
Heart Failure Whistle Stop Talks No 1 HFrEF and HFpEF Definitions for Diagnosis Susie Bowell BA Hons, RGN Heart Failure Specialist Nurse.
Dr. Meg-angela Christi M. Amores
Diastolic Heart Failure “The very essence of cardiovascular medicine is recognition of early heart failure.” Sir Thomas Lewis 1933 “The very essence of.
Anesthetic Considerations for Diastolic Dysfunction
Diastolic Dysfunction Dr. S. Parthasarathy MD., DA., DNB, MD (Acu), Dip. Diab.DCA, Dip. Software statistics PhD (physio)
Heart disease. Congenital Ischemic Hypertensive Valvular Cardiomyopathy Pericardium Tumors.
Investigator Investigator: Sharma Kattel, MBBS Mentor: Mentor: Yuji Saito, MD, PhD, FACP, FACC Department of Internal Medicine Sisters of Charity Hospital.
HEART FAILURE PROF. DR. MUHAMMAD AKBAR CHAUDHRY M.R.C.P.(U.K) F.R.C.P.(E) F.R.C.P.(LONDON) F.A.C.C. DESIGNED AT A.V. DEPTT F.J.M.C. BY RABIA KAZMI.
Ventricular Diastolic Filling and Function
1 Dr. Zahoor Ali Shaikh. 2 CORONARY ARTERY DISEASE (CAD)  CAD is most common form of heart disease and causes premature death.  In UK, 1 in 3 men and.
Heart Failure Khalid F AlHabib.MBBS.FRCPC Cardiology Consultant King Fahad Cardiac Centre King Saud University Wednesday, September 02, 2015Wednesday,
Inflammatory and Structural Heart Disorders Valvular Heart Disease
© Continuing Medical Implementation ® …...bridging the care gap Cardiovascular Aging.
Atrial Fibrillation Andreas Stein Robert Smith, M.D. August 11, 2003.
Causes Myocardial dysfunction eg IHD, CM Volume overload eg AR, MR Obstruction eg AS, HCM Diastolic dysfunction eg Constriction Mechanical problems eg.
Mitral Valve Disease Prof JD Marx UFS January 2006.
Hypertension In elderly population. JNC VII BP Classification SBP mmHgDBP mmHg Normal
Medical Progress: Heart Failure. Primary Targets of Treatment in Heart Failure. Treatment options for patients with heart failure affect the pathophysiological.
Cardio Investigations. Patients presenting with chest pain may be identified as having definite or possible angina from their history alone. Risk Factor.
Differential Diagnosis. Many classes of disorders can result in increased cardiac demand or impaired cardiac function. Cardiac causes include: - arrhythmias.
DIFFERENTIATE: 1. HIGH AND LOW OUTPUT FAILURE RIGHT AND LEFT SIDED HEART FAILURE SYSTOLIC FROM DIASTOLIC DYSFUNCTION Question 9.
The Transition to What you need to know for Cardiology Date | Presenter Information.
Angina & Dysrhythmias. A & P OF THE CARDIAC SYSTEM Cardiac output  CO=SV(stroke volume) X HR(heart rate) Preload  Volume of blood in the ventricles.
Restrictive Physiology is a Major Predictor of Poor Outcomes in Children with Hypertrophic Cardiomyopathy Shiraz A Maskatia MD, Jamie A Decker MD, Joseph.
Frank-Starling Mechanism
Nursing and heart failure
Heart Failure Claire B. Hunter, MD. Heart Failure is the inability of the heart to pump sufficient blood to the body tissue to meet ordinary metabolic.
Heart disease. Congenital Ischemic Hypertensive Valvular Cardiomyopathy Pericardium Tumors.
Systolic Versus Diastolic Failure. Forms of Heart Failure Sytolic Failure Inability of the ventricle to contract normally and expel sufficient blood Inadequate.
Heart Failure. Background to Congestive Heart Failure Normal cardiac output needed to adequately perfuse peripheral organs – Provide O 2, nutrients, etc.
Haissam A Haddad, MD, FRCPC, FACC University of Ottawa Heart Institute
– Dr. J. Satish Kumar, MD, Department of Basic & Medical Sciences, AUST General Medicine CVS Name:________________________________________ Congestive Heart.
Internal Medicine Workshop Series Laos September /October 2009
Physiology of Ventricular Function Dr. Chris Glover Interventional Cardiology Director of Education University of Ottawa Heart Institute January 12, 2015.
 By the end of this lecture the students are expected to:  Explain how cardiac contractility affect stroke volume.  Calculate CO using Fick’s principle.
PHARMACOLOGIC THERAPY  Standard First-Line Therapies Angiotensin-Converting Enzyme Inhibitors (ACEI) β Blockers Diuretics Digoxin  Second line Therapies.
Congestive heart failure Dr/Rehab Gwada. Objectives – Define Congestive Heart Failure. – Outlines the Factors Affecting Cardiac Output – Discuses the.
Cardiac Pathology 3: Valvular Heart Disease, Cardiomyopathies and Other Stuff Kristine Krafts, M.D.
Left Ventricular Filling Pressure by Doppler Echocardiography in Patients With End-Stage Renal Disease Angela Y-M Wang, Mei Wang, Christopher W-K Lam,
William E. Haik, M.D., F.C.C.P. A Clinical Review of the CC/MCC List ©DRG Review, Inc.
Cardiac Catheterization Complication
Heart & Thalassemia . R.Miri,MD, Interventional Cardiologist.
HYPERTENSIVE HEART DISEASE (Hypertensive cardiomyopathy)
Pharmacotherapy Of Cardiovascular Disorders: Heart Failure
Valvular Heart Disease, Cardiomyopathies,
DIASTOLIC DYSFUNCTION and DIASTOLIC HEART FAILURE
Diastolic Heart Failure
Congestive heart failure
LVH & Heart murmur Murmur Increased w/ standing
Diastolic heart failure
Step Care Therapy for Hypertension in Diabetic Patients
Echocardiography findings in HFNEF
Slides courtesy of Dr. Randall Harada
LVH & Heart murmur Murmur Increased w/ standing
Khalid AlHabib Professor of Cardiac Sciences Cardiology Consultant
Presentation transcript:

DIASTOLIC DYSFUNCTION AND HEART FAILURE PHYSIOLOGY, HISTORICAL FEATURES AND CLINICAL PERSPECTIVE Medicine Resident Rounds September 28, 2007 Jacobi Hospital

TERMINOLOGY Diastolic dysfunction –Alteration in active or passive relaxation of the LV Diastolic heart failure –Signs/symptoms of heart failure w normal ventricular function/size and findings of abnormal diastolic function Systolic heart failure –Signs/symptoms of heart failure w abnormal ventricular function/size.

ISOVOLUMIC (EARLY) RELAXATION ENERGY DEPENDENT

Phases of diastole

Elevated Left Ventricular Diastolic Pressure Causes Pulmonary Congestion

HISTORICAL CONCEPTS OF DIASTOLIC FUNCTION Experimental Heart failure was associated with increased diastolic pressures (volume overload or global ischemia) –Objective confirmation of Heart failure was an elevated diastolic pressure (during cardiac catheterization) 1965 Braunwald editorial noting that marked increases observed in hypertrophic hearts without evidence of clinical heart failure Report of reversible diastolic pressure increase without enlargement of the LV heart size during ischemia Non invasive techniques of evaluating diastolic volume changes, wall thickness and LV diastolic diameter

SPONTANEOUS ANGINA EFFECT ON SYSTOLIC & DIASTOLIC PRESSURE

LV DIASTOLIC PRESSURE CHANGES DURING EXERCISE INDUCED ANGINA 50---

CHANGES IN LV DIASTOLIC PRESSURE AND VOLUME DIURING ANGINA -- INDUCED BY ATRIAL PACING DWYER CIRC 1970

LV ANATOMIC CHANGES ALTERS DISTENSIBILITY in CHRONIC NON-ISCHEMIC DISORDERS Myocardial cell Hypertrophy occurs and corresponds to wall thickness as per Echocardiogram Active fibrotic process occurs with increase in the amount of collagen and shift to less pliable collagen

LV DIASTOLIC DISTENSIBILITY Stiffness- Compliance- Distensibility are best quantified by the LV pressure / volume relationship

Assessment of Diastolic Function Echocardiogram –Normal Heart size and normal contraction pattern –E/A flow velocity ratio : in DD E declines and A increases (normal: & Abnormal <1) ; also Abnormal pulmonary venous flow velocity Cardiac Catheterization –Normal heart size and contraction pattern –LV end diastolic pressure (normal =12 mmHg) Greater specificity when 16 mmHg used as upper normal. E A E E A

COMMON CAUSES OF DIASTOLIC DYSFUNCTION Ischemia (potentially reversible delay in or incomplete early relaxation) Acute Hypertension (potentially reversible delay in or incomplete early relaxation) Infarction (increased passive stiffness) Chronic Hypertension with Hypertrophy (increased passive stiffness) Aortic Stenosis & IHSS (increased passive stiffness) Idiopathic Hypertrophic Cardiomyopathy (increased passive stiffness) Diabetes and Obesity (increased passive stiffness)

TRIGGERS TO PULMONARY CONGESTION IN PATIENTS WITH DIASTOLIC DYSFUNCTION Volume overload –Increased salt & water intake –Chronic renal disease –Iatrogenic (procedure or surgery related) –Severe chronic anemia Tachycardia Atrial Fibrillation with and without rapid VR Hypertension (>200 mmHg) Ischemia

R =.44 RELATIONSHIP BETWEEN LV SYSTOLIC PRESSURE AND LV DIASTOLIC PRESSURE IN PATIENTS WITH NORMAL CORONARY ARTERIES DWYER ET AL AHJ 2000

EXERCISE RESPONSE IN DIASTOLIC DYSFUNCTION

ACUTE TREATMENT OF DIASTOLIC HEART FAILURE Reduce intravascular volume carefully – Morphine, diuretic, NTG Control Systolic BP in obvious hypertensive state –Morphine, diuretic, NTG, ACE inhibitors, betablocker Treat any ischemia –NTG, anti-thrombotic Rx, if indicated Control ventricular heart rate –Beta blocker, Ca++ channel blocker

CHRONIC TREATMENT OF DIASTOLIC HEART FAILURE Standard management of underlying disorder(s) In Hypertrophic and/or fibrotic disorders, including hypertension, Diabetes and Obesity, consider ACE inhibitors, ARBs, Spironalactone & beta-blocker to promote regression of LV mass and prevention of further fibrosis. Greater emphasis on maintaining sinus rhythm in patients with paroxysmal atrial fibrillation

RECURRENT PULMONARY EDEMA Rx: SURGICAL INTERVENTION 1985

DIASTOLIC DYSFUNCTION AND OUTCOME SETARO et al 1992; AJC –52 pts WITH CHF & INTACT SYSTOLIC FUNCTION –F/U 7 YRS –50% CAD; 31% HTN –MEAN AGE = 71 COHN et al 1990; CIRC –83 pts –F/U 5 YRS –27% CAD; 53% HTN BROGAN et al 1992;AJM –51 pts –F/U 6 YRS –NO CAD

FRAMINGHAM STUDY VARSAN JACC % CAD 25% CAD

PROGNOSIS OF DIASTOLIC DYSFUNCTION NOMAL CORONARY ARTERIES BRADY & DWYER 2006 Clin Card

SUMMARY Diastolic dysfunction and Diastolic Heart failure is common It is present in many common disorders. Beware and be skeptical of the patient with the diagnosis of “asthma” It’s easy to treat the acute heart failure and fun too! Patients are usually ready to go home within hours and probably can. Managing the progression and chronic state is more problematic. Patients with many admissions with diastolic heart failure is a often physician failure in managing the underlying disorders. Prognosis is heavily influenced by the presence of coronary disease and the age of the patient. Can’t live forever!